Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000038329 | SCV000062000 | likely benign | not specified | 2010-09-02 | criteria provided, single submitter | clinical testing | This variant is not expected to have clinical significance because it does not a lter an amino acid residue and is not located near a splice junction. Therefore, it is unlikely that this variant is disease-causing. |
Gene |
RCV001719752 | SCV000511963 | likely benign | not provided | 2021-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000476490 | SCV000561260 | likely benign | Hypertrophic cardiomyopathy 11; Dilated cardiomyopathy 1R; Atrial septal defect 5 | 2023-10-24 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001180299 | SCV001345194 | likely benign | Cardiomyopathy | 2019-01-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336138 | SCV002638085 | likely benign | Cardiovascular phenotype | 2020-07-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003996400 | SCV004844836 | likely benign | Hypertrophic cardiomyopathy | 2023-12-18 | criteria provided, single submitter | clinical testing |